BridgeBio Supporting a Rare Approach to Drug Development

Public Relations.

BridgeBio, a biopharmaceutical company focused on rare genetic diseases, was formed in order to help bridge the gap between novel scientific discoveries and real-world medicines. Built on a unique subsidiary model, we help tell its story through targeted media relations outreach and thought leadership activities – allowing its bold vision to be brought to light.

BridgeBio, a biopharma company focused on rare diseases, needed to create a cohesive ‘brand family’ for its subsidiary companies. We achieved this through the development of distinct branding and logos for each subsidiary that have shared elements across the companies.